ReNeuron Group Company
ReNeuron Group engages in R&D and the commercial exploitation of stem cell technologies for therapeutic and non-therapeutic applications.
Total Funding:
167 333 065
Acquisitions Number:
1
Headquarters:
Guildford, Surrey, United Kingdom
Funding Status:
IPO
Employee Number:
51-100
Estimated Revenue:
$1M to $10M
Investment Stage:
N/A
Last Funding Type:
Post-IPO Equity
Number Of Exists:
Post-IPO Equity
Technology:
Cell Therapy
Investor Type:
Company
Last Funding Date:
10.07.2015
Investors Number:
4
Founded Date:
01.01.1997
Industry:
Biotechnology